Healthcare decision makers and health insurers increasingly weigh up costs and benefits of innovative therapies and diagnostics. Their decision determines acceptance in service and fee catalogues and remuneration. High quality of your studies determines broad acceptance – MEDIACC actively supports you. We offer knowledge-intensive services to the core strength of cutting-edge technologies in research-oriented enterprises, with the express purpose of leveraging synergies.
Whenever and as long as you need it:
Especially young Start-Ups benefit from an initial potential analysis and the subsequent development of a realisation plan including a structured development plan.
Subsequently a structured development plan will be set up to note down the identified risks of the project and to development of an authoriy-compliant motion for the clinical trial.
The bases for this are scientifically-founded studies, consequent implementation throughout the trial with attention to details. MEDIACC has in-depth knowledge from many years experience from research, academic work and clinical practice. In addition to specialist skill and a professional approach, our clients value our neutrality, speed in the processes and confidentiality. Finding unusual solutions customised to the needs and benefit of our customers are our objectives. Our success rests on the high level of satisfaction of our customers.
Our Senior Project Leaders and Senior Scientific Advisors consult and support you as clients from research, pharmaceutical and biotechnological companies. We are particularly committed to the concerns of small and emerging enterprises.
Our services use approved and continually updated Standard Operating Procedures (SOP). We are utmost committed to keep your project within defined contents, budget and time constraints.
As our clients, you profit from our network of university and extra-university research establishments in the region, as well as international partners. The latest legislations and European directives and regulations are implemented, including international standards (recommendations of World Medical Association (WMA) in the Declaration of Helsinki, guidelines of ICH-GCP (International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human use – Guideline for Good Clinical Practice, guidelines of the European Union (EU), guidelines of the Food and Drug Administration (FDA), CONSORT-Statement, STARD, SAMPL, DIN EN ISO 14155, DIN EN ISO 9001). Expect us to be on the very latest knowledge for your studies.
Our strength lies in efficiency, independence and reliability in the implementation of our customers‘ ideas and visions into successful studies and trials – for expediting time-to-market and peak-market presence. Complete your competences through external specialists.
Shorten the Process Times with MEDIACC.
© 2019 MEDIACC GmbH